Entry |
|
Symbol |
RELA
|
Name |
(RefSeq) RELA proto-oncogene, NF-kB subunit
|
KO |
K04735 | transcription factor p65 |
|
Organism |
csab Chlorocebus sabaeus (green monkey)
|
Pathway |
csab04613 | Neutrophil extracellular trap formation |
csab04620 | Toll-like receptor signaling pathway |
csab04621 | NOD-like receptor signaling pathway |
csab04622 | RIG-I-like receptor signaling pathway |
csab04625 | C-type lectin receptor signaling pathway |
csab04933 | AGE-RAGE signaling pathway in diabetic complications |
csab05022 | Pathways of neurodegeneration - multiple diseases |
csab05166 | Human T-cell leukemia virus 1 infection |
csab05167 | Kaposi sarcoma-associated herpesvirus infection |
csab05170 | Human immunodeficiency virus 1 infection |
csab05202 | Transcriptional misregulation in cancer |
csab05207 | Chemical carcinogenesis - receptor activation |
csab05208 | Chemical carcinogenesis - reactive oxygen species |
csab05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer |
csab05418 | Fluid shear stress and atherosclerosis |
|
Brite |
KEGG Orthology (KO) [BR:csab00001]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
103227364 (RELA)
04014 Ras signaling pathway
103227364 (RELA)
04064 NF-kappa B signaling pathway
103227364 (RELA)
04668 TNF signaling pathway
103227364 (RELA)
04066 HIF-1 signaling pathway
103227364 (RELA)
04071 Sphingolipid signaling pathway
103227364 (RELA)
04024 cAMP signaling pathway
103227364 (RELA)
04151 PI3K-Akt signaling pathway
103227364 (RELA)
09140 Cellular Processes
09141 Transport and catabolism
04137 Mitophagy - animal
103227364 (RELA)
09143 Cell growth and death
04210 Apoptosis
103227364 (RELA)
04218 Cellular senescence
103227364 (RELA)
09150 Organismal Systems
09151 Immune system
04613 Neutrophil extracellular trap formation
103227364 (RELA)
04620 Toll-like receptor signaling pathway
103227364 (RELA)
04621 NOD-like receptor signaling pathway
103227364 (RELA)
04622 RIG-I-like receptor signaling pathway
103227364 (RELA)
04623 Cytosolic DNA-sensing pathway
103227364 (RELA)
04625 C-type lectin receptor signaling pathway
103227364 (RELA)
04660 T cell receptor signaling pathway
103227364 (RELA)
04658 Th1 and Th2 cell differentiation
103227364 (RELA)
04659 Th17 cell differentiation
103227364 (RELA)
04657 IL-17 signaling pathway
103227364 (RELA)
04662 B cell receptor signaling pathway
103227364 (RELA)
04062 Chemokine signaling pathway
103227364 (RELA)
09152 Endocrine system
04920 Adipocytokine signaling pathway
103227364 (RELA)
04917 Prolactin signaling pathway
103227364 (RELA)
04926 Relaxin signaling pathway
103227364 (RELA)
09156 Nervous system
04722 Neurotrophin signaling pathway
103227364 (RELA)
09158 Development and regeneration
04380 Osteoclast differentiation
103227364 (RELA)
09149 Aging
04211 Longevity regulating pathway
103227364 (RELA)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
103227364 (RELA)
05202 Transcriptional misregulation in cancer
103227364 (RELA)
05207 Chemical carcinogenesis - receptor activation
103227364 (RELA)
05208 Chemical carcinogenesis - reactive oxygen species
103227364 (RELA)
05203 Viral carcinogenesis
103227364 (RELA)
05235 PD-L1 expression and PD-1 checkpoint pathway in cancer
103227364 (RELA)
09162 Cancer: specific types
05212 Pancreatic cancer
103227364 (RELA)
05221 Acute myeloid leukemia
103227364 (RELA)
05220 Chronic myeloid leukemia
103227364 (RELA)
05215 Prostate cancer
103227364 (RELA)
05222 Small cell lung cancer
103227364 (RELA)
09172 Infectious disease: viral
05166 Human T-cell leukemia virus 1 infection
103227364 (RELA)
05170 Human immunodeficiency virus 1 infection
103227364 (RELA)
05161 Hepatitis B
103227364 (RELA)
05160 Hepatitis C
103227364 (RELA)
05171 Coronavirus disease - COVID-19
103227364 (RELA)
05164 Influenza A
103227364 (RELA)
05162 Measles
103227364 (RELA)
05168 Herpes simplex virus 1 infection
103227364 (RELA)
05163 Human cytomegalovirus infection
103227364 (RELA)
05167 Kaposi sarcoma-associated herpesvirus infection
103227364 (RELA)
05169 Epstein-Barr virus infection
103227364 (RELA)
05165 Human papillomavirus infection
103227364 (RELA)
09171 Infectious disease: bacterial
05132 Salmonella infection
103227364 (RELA)
05135 Yersinia infection
103227364 (RELA)
05133 Pertussis
103227364 (RELA)
05134 Legionellosis
103227364 (RELA)
05152 Tuberculosis
103227364 (RELA)
09174 Infectious disease: parasitic
05146 Amoebiasis
103227364 (RELA)
05145 Toxoplasmosis
103227364 (RELA)
05140 Leishmaniasis
103227364 (RELA)
05142 Chagas disease
103227364 (RELA)
09163 Immune disease
05321 Inflammatory bowel disease
103227364 (RELA)
09164 Neurodegenerative disease
05010 Alzheimer disease
103227364 (RELA)
05022 Pathways of neurodegeneration - multiple diseases
103227364 (RELA)
09165 Substance dependence
05030 Cocaine addiction
103227364 (RELA)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
103227364 (RELA)
05418 Fluid shear stress and atherosclerosis
103227364 (RELA)
05415 Diabetic cardiomyopathy
103227364 (RELA)
09167 Endocrine and metabolic disease
04936 Alcoholic liver disease
103227364 (RELA)
04932 Non-alcoholic fatty liver disease
103227364 (RELA)
04931 Insulin resistance
103227364 (RELA)
04933 AGE-RAGE signaling pathway in diabetic complications
103227364 (RELA)
09176 Drug resistance: antineoplastic
01523 Antifolate resistance
103227364 (RELA)
09180 Brite Hierarchies
09182 Protein families: genetic information processing
03000 Transcription factors [BR:csab03000]
103227364 (RELA)
Transcription factors [BR:csab03000]
Eukaryotic type
beta-Scaffold factors with minor groove contacts
RHR (Rel homology region) Rel/Ankyrin
103227364 (RELA)
|
SSDB |
|
Motif |
|
Other DBs |
|
LinkDB |
|
Position |
1:8576059..8585561
|
AA seq |
551 aa
MDELFPLIFPAEPAQASGPYVEIIEQPKQRGMRFRYKCEGRSAGSIPGERSTDTTKTHPT
IKINGYTGPGTVRISLVTKDPPHRPHPHELVGKDCRDGFYEAELCPDRCIHSFQNLGIQC
VKKRDLEQAITQRIQTNNNPFQVPIEEQRGDYDLNAVRLCFQVTVRDPSGRPLRLPPVLS
HPIFDNRAPNTAELKICRVNRNSGSCLGGDEIFLLCDKVQKEDIEVYFTGPGWEARGSFS
QADVHRQVAIVFRTPPYADPSLQAPVRVSMQLRRPSDRELSEPMEFQYLPDTDDRHRIEE
KRKRTYETFKSIMKKSPFSGPTDPRPPPRRIAVPSRTSASVPKPAPQPYPFTSSLSTINY
DEFPTMVFPSGQISQASALASAPPQVLPQAPAPAPAPAMVSALAQAPVPVPVLAPGPPQA
VAPPAPKPTQAGEGTLSEALLQLQFDDEDLGALLGNSTDPTVFTDLASVDNSEFQQLLNQ
GVPVAPHTTEPMLMEYPEAITRLVTGAQRPPDPAPAPLGAPGLPNGLLSGDEDFSSIADM
DFSALLSQISS |
NT seq |
1656 nt +upstreamnt +downstreamnt
atggacgaactgttccccctcatcttcccggcagagccagcccaggcctctggcccctat
gtggagatcattgagcagcccaagcagcggggcatgcgcttccgctacaagtgcgagggg
cgctccgcgggcagcatcccaggcgagaggagcacagataccaccaagacccaccccacc
atcaagatcaatggctacacaggaccagggacagtacgcatctccctagtcaccaaggac
cctcctcaccggcctcacccccacgagcttgtaggaaaggactgccgggatggcttctat
gaggctgagctctgcccggaccgctgcatccacagtttccagaacctgggaatccagtgt
gtgaagaagcgggacctggagcaggctatcactcagcgcatccagacgaacaacaatccc
ttccaagttcctatagaagaacagcgtggggactacgacctgaatgctgtgcggctctgc
ttccaggtgacagtgcgggatccatcaggcaggcccctccgcctgccgcctgtcctttct
catcccatctttgacaaccgtgcccccaacactgccgaactcaagatctgccgagtgaac
cgaaactctggcagctgcctcggtggggatgagatcttcctactgtgtgacaaggtgcag
aaagaggacattgaggtgtatttcacgggaccaggctgggaggcccgaggctccttttcg
caagctgatgtgcaccgacaagtggccattgtgttccggacccctccctacgcagacccc
agcctgcaggctcccgtgcgtgtctccatgcagctgcggcggccttccgaccgggagctc
agtgagcccatggaattccagtacctgccagatacagacgatcgtcaccggatcgaggag
aaacgcaaaaggacatatgagaccttcaagagcatcatgaagaagagtcctttcagcgga
cccactgacccccggcctccacctcggcgcattgctgtgccttcccgcacctcagcttct
gttcccaagccagcaccccagccctatccctttacgtcatccctgagcaccatcaactat
gatgagtttcccaccatggtgtttccttctgggcagataagccaggcctcagccttggcc
tcggcccctccccaagtcctgccccaggctccagcccctgcccctgctccagccatggta
tcagctctggcccaggccccagtccctgtcccagtcctagccccaggccctcctcaggct
gtggccccacctgcccccaagcccacccaggctggggaaggaacgctgtcagaggccttg
ctgcagctgcagtttgatgatgaagacctgggggccttgcttggcaacagcacagaccca
accgtgttcacagacctggcatcagtcgacaactccgagtttcagcagctgctgaaccag
ggcgtacctgtggccccccacacaactgagcccatgctcatggagtaccctgaggctata
actcgcctagtgacaggggcccagaggccccctgacccagctcctgctccactgggggcc
ccggggctccccaacggcctcctttcaggagatgaagacttctcctccattgcggacatg
gacttctcagccctgctgagtcagatcagctcctaa |